狼疮肾炎患者T细胞SLAM受体表达改变及作为疾病活动生物标志物的潜力
研究纳入30例经活检证实的狼疮肾炎(LN)SLE患者,用流式细胞术检测T细胞亚群上SLAM家族受体表达并结合临床疾病活动度分析。缓解期LN患者表达SLAMF3、SLAMF5和SLAMF7的CD8 T细胞频率显著降低,活动期患者则与健康人相似;DN T细胞SLAMF6阳性比例或可预测对B细胞清除治疗的临床应答。结果提示SLAM信号通路参与狼疮发病,其受体表达改变可能作为疾病活动相关生物标志物。
要点
- 缓解期LN患者SLAMF3、SLAMF5、SLAMF7阳性CD8 T细胞频率显著降低。
- 活动性肾炎患者循环单核细胞百分比升高,或参与肾小球炎症。
- DN T细胞SLAMF6阳性比例或可预测LN对B细胞清除治疗的临床应答。
核心结论
- SLE患者T淋巴细胞存在SLAM家族受体表达改变,支持SLAM相关通路在狼疮发病中具有重要作用。
- 表达SLAMF3、SLAMF5和SLAMF7的CD8 T细胞频率在缓解期LN患者中显著降低,活动期患者与健康人相似。
- DN T细胞表达SLAMF6的百分比或可预测LN患者对B细胞清除治疗的临床应答。
研究设计与样本
- 外周血单个核细胞来自30例经活检证实的LN的SLE患者,采用流式细胞术分析。
- 检测CD4、CD8及双阴性(DN)T细胞亚群上SLAM家族受体表达,并评估临床疾病活动度指标。
- 比较活动性肾脏病变患者与缓解期患者之间SLAM家族受体表达的差异。
主要发现
- 缓解期LN患者中表达SLAMF3、SLAMF5和SLAMF7的CD8 T细胞频率显著低于活动期患者及健康人。
- 活动性肾炎患者循环单核细胞百分比升高,提示其在肾小球炎症中可能发挥作用。
- 无论疾病活动度如何,LN患者DN T细胞中SLAMF2、SLAMF4和SLAMF7阳性频率均出现变化。
- 细胞水平SLAM家族受体表达的改变较不明显,且未呈现特定模式。
- DN T细胞表达SLAMF6的百分比或可预测LN患者对B细胞清除治疗的临床应答。
临床怎么用
- SLAMF3、SLAMF5、SLAMF7阳性CD8 T细胞频率降低与LN缓解状态相关,可作为评估疾病活动的候选指标。
- DN T细胞SLAMF6表达或有助于在B细胞清除治疗前预判LN患者的临床应答。
- SLAM家族受体表达改变支持SLAM相关通路作为狼疮治疗潜在靶点的进一步研究。
局限性
- 样本量为30例经活检证实的LN患者,样本量有限。
- 细胞水平SLAM家族受体表达改变较不明显且未呈现特定模式,检测稳定性有限。
- SLAMF6预测B细胞清除治疗应答的结论需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim was to investigate whether the signalling lymphocyte activation molecule (SLAM) signalling pathways contribute to LN and whether SLAM receptors could be valuable biomarkers of disease activity. METHODS: Peripheral blood mononuclear cells from 30National Research Ethics Service SLE patients with biopsy-proven LN were analysed by flow cytometry. Clinical measures of disease activity were assessed. The expression of the SLAM family receptors on T-cell subpopulations [CD4, CD8 and double negative (DN) T cells] was measured and compared between lupus patients with active renal disease and those in remission. RESULTS: The frequency of CD8 T cells expressing SLAMF3, SLAMF5 and SLAMF7 was significantly lower in LN patients who were in remission. In contrast, these subsets were similar in patients with active renal disease and in healthy individuals. Patients with active nephritis had an increased percentage of circulating monocytes, consistent with a potential role played by these cells in glomerular inflammation. Changes in the frequency of DN T cells positive for SLAMF2, SLAMF4 and SLAMF7 were observed in lupus patients irrespective of the disease activity. We detected alterations in the cellular expression of the SLAM family receptors, but these changes were less obvious and did not reveal any specific pattern. The percentage of DN T cells expressing SLAMF6 could predict the clinical response to B-cell depletion in patients with LN. CONCLUSION: Our study demonstrates altered expression of the SLAM family receptors in SLE T lymphocytes. This is consistent with the importance of the SLAM-associated pathways in lupus pathogenesis.
引用
- Stratigou V, Doyle AF, Carlucci F, et al. Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity. Rheumatology (Oxford). 2017. PMID: 28387859. doi:10.1093/rheumatology/kex078
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。